Mallinckrodt Pharmaceuticals
MNK
#10200
Rank
ยฃ3.39 M
Marketcap
ยฃ0.26
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Mallinckrodt Pharmaceuticals (MNK)

Earnings in 2023 (TTM): -ยฃ0.96 Billion

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ1.93 Billion. In 2022 the company made an earning of -ยฃ1.1 Billion a decrease over its 2021 earnings that were of -ยฃ0.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -ยฃ0.96 Billion-12.62%
2022 -ยฃ1.1 Billion76.14%
2021 -ยฃ0.63 Billion-13.63%
2020 -ยฃ0.73 Billion-39.63%
2019 -ยฃ1.2 Billion-61.51%
2018 -ยฃ3.11 Billion-6812.18%
2017 ยฃ46.26 M-185.79%
2016 -ยฃ53.93 Million-131.27%
2015 ยฃ0.17 B-166.82%
2014 -ยฃ0.26 Billion-319.69%
2013 ยฃ0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ13.09 B-1,616.56%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.16 Billion-81.56%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.22 Billion-75.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
ยฃ6.38 B-839.07%๐Ÿ‡บ๐Ÿ‡ธ USA